Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.

The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...

Zycubo is a copper replacement therapy administered via subcutaneous injection to bypass impaired GI absorption in patients with Menkes disease.

'Unanswered Questions' reported that the person called 'injection aunt' may have been a foreign patient recruitment agent rather than a medical professional, raising serious concerns about ...

Three years after its initial FDA approval, Roche has made up for an early disadvantage with its blood cancer drug Lunsumio amid competition among CD20xCD3 bispecific antibodies. The FDA has approved ...

Is photo of Donald Trump using a walker real? What to know FDA intends to put its most serious warning on COVID vaccines, sources say California home explosion caught on doorbell camera Professors are ...

The FDA approved a subcutaneous formulation of the blockbuster cancer drug pembrolizumab (Keytruda Qlex) for use across the drug's numerous solid tumors indications. The new formulation combines ...

Please provide your email address to receive an email when new articles are posted on . Leqembi Iqlik is the first approved in-home anti-amyloid injectable for early Alzheimer’s disease. Patients ...

The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of lecanemab (Leqembi Iqlik) for weekly maintenance dosing to treat Alzheimer’s ...

Like many doctors, I often encountered patients suffering from musculoskeletal pain who had tried a variety of allopathic and natural treatment modalities with limited or no success. In many cases, I ...